Nasdaq · Laboratory Analytical Instruments
9 entities across 7 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-03-02 — see the exhibit.
| Entity | Jurisdiction | Note |
|---|---|---|
| Akoya Biosciences, Inc. | Delaware | |
| Akoya Biosciences UK Ltd. | United Kingdom | |
| Aushon Biosystems, Inc. | Delaware | |
| Emission Inc. | Delaware | |
| Quanterix Bio-tech (Shanghai) Co., Ltd | China | |
| Quanterix Holdings (Hong Kong) Limited | Hong Kong | |
| Quanterix Netherlands B.V. | The Netherlands | |
| Quanterix Security Corporation | Massachusetts | |
| UmanDiagnostics AB | Sweden |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2023 | — | — | — | — | — |
| FY2023 | — | — | — | — | — |
| FY2023 | — | — | — | — | — |
| FY2023 | $122.4M | −$32.3M | −$22.7M | 57.7% | 37,594,000 |
| FY2024 | $137.4M | −$38.5M | −$38.5M | 60.5% | 38,367,000 |
| FY2025 | $138.9M | −$107.2M | −$79.8M | 46.8% | 42,639,000 |
10 institutions tracked — 8 added, 2 reduced.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| MORGAN STANLEY | Active fund | 447,688 | −160,168 | $1.9M |
| CITADEL ADVISORS LLC | Hedge fund | 229,736 | +142,135 | $992,460 |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 1,131,377 | +136,613 | $4.9M |
| STATE STREET CORP | Index | 932,307 | +34,030 | $4.0M |
| VANGUARD GROUP INC | Index | 2,677,833 | +30,318 | $17.0M |
| FMR LLC | Active fund | 210,634 | +27,278 | $909,940 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 95,626 | +27,254 | $414,000 |
| BANK OF AMERICA CORP /DE/ | Active fund | 29,286 | −20,266 | $126,516 |
| BlackRock Finance, Inc. | Index | 3,137,432 | +14,954 | $41.4M |
| JPMORGAN CHASE & CO | Active fund | 19,049 | +1,638 | $86,483 |
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register. These filings span 2024-Q2–2026-Q2 rather than a single quarter, because filers report on their own schedules.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Quanterix Corp files under SIC 3826 — all 12 laboratory analytical instruments companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
